The Pilot Feasibility Core of the Developmental Synaptopathies Consortium (DSC) is pleased to announce it will fund an estimated $30,000 total costs per project (three in total) to stimulate additional research in Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Syndrome (PHTS) and Phelan-McDermid Syndrome (PMS) through the DSC NIH grant. The funding will be coordinated, dispersed and evaluated for progress through the DSC infrastructure.

Applications are due Friday, April 15, 2022.